GSK Reports a Robust £8 Billion in Q2 Sales with Specialty Medicines Leading the Charge
GSK plc announced a 1% year-over-year sales increase to £8 billion in Q2 2025, with Specialty Medicines driving growth. Earnings per share and operating profit also saw significant...